Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

A woman with skin eruptions and hair loss improved significantly with ointment treatment.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Er:YAG laser therapy is ineffective for treating facial eruptive vellus hair cysts due to early recurrence and side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Alcoholic extract of Eclipta alba may help treat allergies and is safe at high doses.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Baricitinib may help people with long-term alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Pediatric patients with dystrophic epidermolysis bullosa face more hospital admissions, procedures, and complications than others.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

New ultrasound criteria for diagnosing PCOS in North African patients were successfully established.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

The structured oral exam format is effective and well-received for teaching internal medicine.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.